NCT03861975View on ClinicalTrials.gov

Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening

NAActive, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2026

Conditions

Breast Cancer

Interventions

OTHER

Breast Cancer-Related Lymphedema Measurements

All patients will receive bilateral arm measurements using the LymphaTech Scanner and the Perometer.

Trial Locations (1)

02114

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors

collaborator

Heinz Family Foundation

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT03861975 - Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening | Biotech Hunter | Biotech Hunter